Effect of heat-killed Lactobacillus paracasei KW3110 ingestion on ocular disorders caused by visual display terminal (VDT) loads: A randomized, double-blind, placebo-controlled parallel-group study

Nutrients

Volumn 10, Issue 8, 2018, Pages

  Morita, Yuji ^a   Jounai, Kenta ^b   Miyake, Mika ^a   Inaba, Masaharu ^c   Kanauchi, Osamu ^a  

^a KIRIN HOLDINGS CO LTD   (Japan)

^b Shizukuishi Iwate Gun   (Japan)

^c Inaba Ganka Eye Clinic   (Japan)

Author keywords

Eye fatigue; Lactobacillus paracasei KW3110; Probiotics; VDT

Indexed keywords

INTERLEUKIN 10; PLACEBO; PROBIOTIC AGENT;

ADULT; ARPE-19 CELL LINE; ARTICLE; BLUE LIGHT; BLURRED VISION; CELL DAMAGE; CELL METABOLISM; CONTRAST SENSITIVITY; CONTROLLED STUDY; CRITICAL FLICKER FUSION; DIET SUPPLEMENTATION; DIPLOPIA; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFICACY; DRY EYE RELATED QUALITY OF LIFE SCORE; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE DISEASE; EYE FATIGUE; EYE PAIN; EYE REDNESS; FEMALE; FROZEN SHOULDER; FRUSTRATION; HEADACHE; HUMAN; HUMAN CELL; INGESTION; LACTOBACILLUS PARACASEI; LIGHT EXPOSURE; MACROPHAGE CULTURE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PARALLEL DESIGN; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; RETINA INJURY; RETINA TEAR; VISUAL ANALOG SCALE; WST-8 ASSAY; ASTHENOPIA; CELL LINE; COMPUTER TERMINAL; CONVALESCENCE; HEAT; JAPAN; LIGHT; MICROBIOLOGY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIATION RESPONSE; RETINAL PIGMENT EPITHELIUM; TIME FACTOR; TREATMENT OUTCOME; VISION;

ADULT; ASTHENOPIA; CELL LINE; COMPUTER TERMINALS; DOUBLE-BLIND METHOD; FEMALE; HOT TEMPERATURE; HUMANS; JAPAN; LACTOBACILLUS PARACASEI; LIGHT; MALE; MIDDLE AGED; PROBIOTICS; RECOVERY OF FUNCTION; RETINAL PIGMENT EPITHELIUM; TIME FACTORS; TREATMENT OUTCOME; VISION, OCULAR;

EID: 85051512092     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10081058     Document Type: Article

References (53)

1. Bergqvist, U. Possible health effects of working with vdus. Br. J. Ind. Med. 1989, 46, 217–221.
2. Knave, B.G.; Wibom, R.I.; Voss, M.; Hedstrom, L.D.; Bergqvist, U.O. Work with video display terminals among office employees. I. Subjective symptoms and discomfort. Scand. J. Work Environ. Health 1985, 11, 457–466.
3. Eltayeb, S.; Staal, J.B.; Hassan, A.; de Bie, R.A. Work related risk factors for neck, shoulder and arms complaints: A cohort study among dutch computer office workers. J. Occup. Rehabil. 2009, 19, 315–322.
4. Parihar, J.K.; Jain, V.K.; Chaturvedi, P.; Kaushik, J.; Jain, G.; Parihar, A.K. Computer and visual display terminals (vdt) vision syndrome (cvdts). Med. J. Armed Forces India 2016, 72, 270–276.
5. Aronsson, G.; Stromberg, A. Work content and eye discomfort in vdt work. Int. J. Occup. Saf. Ergon. 1995, 1, 1–13.
6. Murata, K.; Araki, S.; Kawakami, N.; Saito, Y.; Hino, E. Central nervous system effects and visual fatigue in vdt workers. Int. Arch. Occup. Environ. Health 1991, 63, 109–113.
7. Murata, K.; Araki, S.; Yokoyama, K.; Yamashita, K.; Okumatsu, T.; Sakou, S. Accumulation of vdt work-related visual fatigue assessed by visual evoked potential, near point distance and critical flicker fusion. Ind. Health 1996, 34, 61–69.
8. Goto, E.; Yagi, Y.; Matsumoto, Y.; Tsubota, K. Impaired functional visual acuity of dry eye patients. Am. J. Ophthalmol. 2002, 133, 181–186.
9. Uchino, M.; Schaumberg, D.A.; Dogru, M.; Uchino, Y.; Fukagawa, K.; Shimmura, S.; Satoh, T.; Takebayashi, T.; Tsubota, K. Prevalence of dry eye disease among japanese visual display terminal users. Ophthalmology 2008, 115, 1982–1988.
10. Thomson, W.D. Eye problems and visual display terminals—The facts and the fallacies. Ophthalmic Physiol. Opt. 1998, 18, 111–119.
11. Ye, Z.; Abe, Y.; Kusano, Y.; Takamura, N.; Eida, K.; Takemoto, T.; Aoyagi, K. The influence of visual display terminal use on the physical and mental conditions of administrative staff in japan. J. Physiol. Anthropol. 2007, 26, 69–73.
12. Friedman, N.J. Impact of dry eye disease and treatment on quality of life. Curr. Opin. Ophthalmol. 2010, 21, 310–316.
13. Vilela, M.A.; Pellanda, L.C.; Fassa, A.G.; Castagno, V.D. Prevalence of asthenopia in children: A systematic review with meta-analysis. J. Pediatr. 2015, 91, 320–325.
14. Collier, J.D.; Rosenfield, M. Accommodation and convergence during sustained computer work. Optometry 2011, 82, 434–440.
15. Kurimoto, S.; Iwasaki, T.; Nomura, T.; Noro, K.; Yamamoto, S. Influence of vdt (visual display terminals) work on eye accommodation. J. UOEH 1983, 5, 101–110.
16. Kajita, M.; Ono, M.; Suzuki, S.; Kato, K. Accommodative microfluctuation in asthenopia caused by accommodative spasm. Fukushima J. Med. Sci. 2001, 47, 13–20.
17. Portello, J.K.; Rosenfield, M.; Chu, C.A. Blink rate, incomplete blinks and computer vision syndrome. Optom. Vis. Sci. 2013, 90, 482–487.
18. Uchino, Y.; Uchino, M.; Dogru, M.; Fukagawa, K.; Tsubota, K. Improvement of accommodation with antioxidant supplementation in visual display terminal users. J. Nutr. Health Aging 2012, 16, 478–481.
19. Choi, W.; Kim, J.C.; Kim, W.S.; Oh, H.J.; Yang, J.M.; Lee, J.B.; Yoon, K.C. Clinical effect of antioxidant glasses containing extracts of medicinal plants in patients with dry eye disease: A multi-center, prospective, randomized, double-blind, placebo-controlled trial. PLoS ONE 2015, 10, e0139761.
20. Snodderly, D.M. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am. J. Clin. Nutr. 1995, 62, 1448S–1461S.
21. Lee, J.; Lee, H.K.; Kim, C.Y.; Hong, Y.J.; Choe, C.M.; You, T.W.; Seong, G.J. Purified high-dose anthocyanoside oligomer administration improves nocturnal vision and clinical symptoms in myopia subjects. Br. J. Nutr. 2005, 93, 895–899.
22. Wang, L.J.; Su, S.; Wu, J.; Du, H.; Li, S.S.; Huo, J.W.; Zhang, Y.; Wang, L.S. Variation of anthocyanins and flavonols in vaccinium uliginosum berry in lesser khingan mountains and its antioxidant activity. Food Chem. 2014, 160, 357–364.
23. Galbis-Estrada, C.; Pinazo-Duran, M.D.; Martinez-Castillo, S.; Morales, J.M.; Monleon, D.; Zanon-Moreno, V. A metabolomic approach to dry eye disorders. The role of oral supplements with antioxidants and omega 3 fatty acids. Mol. Vis. 2015, 21, 555–567.
24. Neuringer, M. Infant vision and retinal function in studies of dietary long-chain polyunsaturated fatty acids: Methods, results, and implications. Am. J. Clin. Nutr. 2000, 71, 256S–267S.
25. Bhargava, R.; Kumar, P.; Phogat, H.; Kaur, A.; Kumar, M. Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. Contact Lens Anterior Eye 2015, 38, 206–210.
26. Rutar, M.; Natoli, R.; Provis, J.M. Small interfering rna-mediated suppression of ccl2 in muller cells attenuates microglial recruitment and photoreceptor death following retinal degeneration. J. Neuroinflamm. 2012, 9, 221.
27. Jiao, H.; Natoli, R.; Valter, K.; Provis, J.M.; Rutar, M. Spatiotemporal cadence of macrophage polarisation in a model of light-induced retinal degeneration. PLoS ONE 2015, 10, e0143952.
28. Miyake, S.; Takahashi, N.; Sasaki, M.; Kobayashi, S.; Tsubota, K.; Ozawa, Y. Vision preservation during retinal inflammation by anthocyanin-rich bilberry extract: Cellular and molecular mechanism. Lab. Investig. 2012, 92, 102–109.
29. Fontana, L.; Bermudez-Brito, M.; Plaza-Diaz, J.; Munoz-Quezada, S.; Gil, A. Sources, isolation, characterisation and evaluation of probiotics. Br. J. Nutr. 2013, 109 (Suppl. S2), S35–S50.
30. Ichikawa, S.; Fujii, R.; Fujiwara, D.; Komiyama, Y.; Kaisho, T.; Sakaguchi, M.; Konishi, Y. Myd88 but not tlr2, 4 or 9 is essential for il-12 induction by lactic acid bacteria. Biosci. Biotechnol. Biochem. 2007, 71, 3026– 3032.
31. Wakabayashi, H.; Nariai, C.; Takemura, F.; Nakao, W.; Fujiwara, D. Dietary supplementation with lactic acid bacteria attenuates the development of atopic-dermatitis-like skin lesions in nc/nga mice in a strain-dependent manner. Int. Arch. Allergy Immunol. 2008, 145, 141–151.
32. Fujiwara, D.; Inoue, S.; Wakabayashi, H.; Fujii, T. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both th1/th2 cytokine expression and balance. Int. Arch. Allergy Immunol. 2004, 135, 205–215.
33. Ichikawa, S.; Miyake, M.; Fujii, R.; Konishi, Y. Orally administered lactobacillus paracasei kw3110 induces in vivo il-12 production. Biosci. Biotechnol. Biochem. 2009, 73, 1561–1565.
34. Moriguchi S. “Nikkagiren Suchihyo” [Numerical Scheme]; JUSE Press: Tokyo, Japan, 1968; Volume 80, pp. 37– 43. (In Japanese)
35. Richer, S.; Stiles, W.; Statkute, L.; Pulido, J.; Frankowski, J.; Rudy, D.; Pei, K.; Tsipursky, M.; Nyland, J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: The veterans last study (lutein antioxidant supplementation trial). Optometry 2004, 75, 216–230.
36. Sakane, Y.; Yamaguchi, M.; Yokoi, N.; Uchino, M.; Dogru, M.; Oishi, T.; Ohashi, Y.; Ohashi, Y. Development and validation of the dry eye-related quality-of-life score questionnaire. JAMA Ophthalmol. 2013, 131, 1331– 1338.
37. Kaji, R.; Kiyoshima-Shibata, J.; Nagaoka, M.; Nanno, M.; Shida, K. Bacterial teichoic acids reverse predominant il-12 production induced by certain lactobacillus strains into predominant il-10 production via tlr2-dependent erk activation in macrophages. J. Immunol. 2010, 184, 3505–3513.
38. Herz, J.; Filiano, A.J.; Smith, A.; Yogev, N.; Kipnis, J. Myeloid cells in the central nervous system. Immunity 2017, 46, 943–956.
39. Martinez, F.O.; Helming, L.; Gordon, S. Alternative activation of macrophages: An immunologic functional perspective. Annu. Rev. Immunol. 2009, 27, 451–483.
40. Biswas, S.K.; Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: Cancer as a paradigm. Nat. Immunol. 2010, 11, 889–896.
41. Sica, A.; Mantovani, A. Macrophage plasticity and polarization: In vivo veritas. J. Clin. Investig. 2012, 122, 787–795.
42. Satoh, T.; Kidoya, H.; Naito, H.; Yamamoto, M.; Takemura, N.; Nakagawa, K.; Yoshioka, Y.; Morii, E.; Takakura, N.; Takeuchi, O.; et al. Critical role of trib1 in differentiation of tissue-resident m2-like macrophages. Nature 2013, 495, 524–528.
43. London, A.; Itskovich, E.; Benhar, I.; Kalchenko, V.; Mack, M.; Jung, S.; Schwartz, M. Neuroprotection and progenitor cell renewal in the injured adult murine retina requires healing monocyte-derived macrophages. J. Exp. Med. 2011, 208, 23–39.
44. Lau, L.I.; Chiou, S.H.; Liu, C.J.; Yen, M.Y.; Wei, Y.H. The effect of photo-oxidative stress and inflammatory cytokine on complement factor H expression in retinal pigment epithelial cells. Investig. Ophthalmol. Vis. Sci. 2011, 52, 6832–6841.
45. Lin, J.B.; Gerratt, B.W.; Bassi, C.J.; Apte, R.S. Short-wavelength light-blocking eyeglasses attenuate symptoms of eye fatigue. Investig. Ophthalmol. Vis. Sci. 2017, 58, 442–447.
46. Ayaki, M.; Hattori, A.; Maruyama, Y.; Nakano, M.; Yoshimura, M.; Kitazawa, M.; Negishi, K.; Tsubota, K. Protective effect of blue-light shield eyewear for adults against light pollution from self-luminous devices used at night. Chronobiol. Int. 2016, 33, 134–139.
47. Maeda, E.; Yoshikawa, T.; Hayashi, N.; Akai, H.; Hanaoka, S.; Sasaki, H.; Matsuda, I.; Yoshioka, N.; Ohtomo, K. Radiology reading-caused fatigue and measurement of eye strain with critical flicker fusion frequency. Jpn. J. Radiol. 2011, 29, 483–487.
48. Luczak, A.; Sobolewski, A. Longitudinal changes in critical flicker fusion frequency: An indicator of human workload. Ergonomics 2005, 48, 1770–1792.
49. Cai, T.; Zhu, H.; Xu, J.; Wu, S.; Li, X.; He, S. Human cortical neural correlates of visual fatigue during binocular depth perception: An fnirs study. PLoS ONE 2017, 12, e0172426.
50. Matsunaga, N.; Imai, S.; Inokuchi, Y.; Shimazawa, M.; Yokota, S.; Araki, Y.; Hara, H. Bilberry and its main constituents have neuroprotective effects against retinal neuronal damage in vitro and in vivo. Mol. Nutr. Food Res. 2009, 53, 869–877.
51. Ozawa, Y.; Kawashima, M.; Inoue, S.; Inagaki, E.; Suzuki, A.; Ooe, E.; Kobayashi, S.; Tsubota, K. Bilberry extract supplementation for preventing eye fatigue in video display terminal workers. J. Nutr. Health Aging 2015, 19, 548–554.
52. Matsumoto, H.; Kamm, K.E.; Stull, J.T.; Azuma, H. Delphinidin-3-rutinoside relaxes the bovine ciliary smooth muscle through activation of etb receptor and no/cgmp pathway. Exp. Eye Res. 2005, 80, 313–322.
53. Uchino, M.; Yokoi, N.; Uchino, Y.; Dogru, M.; Kawashima, M.; Komuro, A.; Sonomura, Y.; Kato, H.; Kinoshita, S.; Schaumberg, D.A.; et al. Prevalence of dry eye disease and its risk factors in visual display terminal users: The osaka study. Am. J. Ophthalmol. 2013, 156, 759–766.